KK
ADMA icon

KLP Kapitalforvaltning’s ADMA Biologics ADMA Stock Holding History

KLP Kapitalforvaltning’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$439K Hold
52,500
– – ﹤0.01% 1558
2026
Q1 		$473K Buy
52,500
+1,500
+3% +$23.7K ﹤0.01% 1448
2025
Q4 		$930K Buy
51,000
+1,300
+3% +$21.9K ﹤0.01% 1068
2025
Q3 		$729K Hold
49,700
– – ﹤0.01% 1207
2025
Q2 		$905K Buy
49,700
+3,400
+7% +$69.3K ﹤0.01% 1040
2025
Q1 		$919K Hold
46,300
– – ﹤0.01% 976
2024
Q4 		$794K Buy
+46,300
New +$871K ﹤0.01% 1095

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

KLP Kapitalforvaltning's ADMA Position: Q2 2026 in Review

KLP Kapitalforvaltning held its ADMA Biologics (ADMA) position steady in Q2 2026 at 52,500 shares worth $439K. The position accounts for ﹤0.01% of the portfolio, ranked #1558.

KLP Kapitalforvaltning first reported a position in ADMA in Q4 2024 and has held it in 7 quarters since. The position peaked at $930K in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • KLP Kapitalforvaltning held 52,500 shares of ADMA Biologics worth $439K as of Q2 2026.
  • KLP Kapitalforvaltning left its ADMA Biologics share count unchanged in Q2 2026.
  • ADMA Biologics made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1558 holding.
  • KLP Kapitalforvaltning first reported a position in ADMA Biologics in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's ADMA Biologics position peaked at $930K in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.